A high-five to everyone who chose to decline an invitation to an office party last Thursday and who opened up slack this morning to dozens of messages from sick people because it turned into a super spreader. Moxxi is proud of you.
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: A new study finds SARS-CoV-2 directly infects the coronary
vasculature and causes plaque inflammation, which could help explain
why people with COVID-19 have an increased risk for ischemic
cardiovascular complications up to 1 year after infection (see
"COVID-19 Virus Infects Coronary Vasculature" under COVID
Complications).
People with rheumatic disease and a history of a specific type of cold
virus infection called OC43 are at elevated risk for developing long
COVID (see "A Common Cold Might Set Some Up for Long COVID" under
Virology & Epidemiology).
Two scientists who pioneered an underlying technology to harness
fragile genetic material in a way that ultimately resulted in the mRNA
vaccines used to combat the COVID-19 pandemic were named winners of
the Nobel Prize in medicine (see "Pair of Trailblazers of mRNA Vaccine
Science Win Nobel Prize" under Media News).
When used against current strains of COVID-19, Pfizer's antiviral
Paxlovid is less effective at preventing hospitalization or death in
high-risk patients. But when looking at death alone, the antiviral is
still highly effective (see "Paxlovid Weaker Against Current COVID-19
Variants" under Vaccinations, Treatment & Testing).
Average levels of SARS-CoV-2, the virus that causes COVID, being found
in wastewater are down about 5%, compared to last week (see
"Wastewater Data Hint at Possible COVID Decline in Some Areas" under
Virology & Epidemiology).
A panel of independent advisers to the Centers for Disease Control and
Prevention (CDC) will meet next month to make recommendations on
updated COVID-19 vaccines ahead of the fall season (see "CDC Advisers
Set to Vote on Updated COVID Vaccines Next Month" under Policy).
A long-term study indicates a correlation between COVID-19 and lasting
cardiovascular impairment (see "Cardiovascular Assessment up to One
Year After COVID-19 Vaccine–Associated Myocarditis" under COVID
Complications).
Mean weekly cannabis-involved ED visits among all young persons were
higher during the COVID-19 pandemic in 2020, 2021, and 2022 (see
"Cannabis-Involved Emergency Department Visits Among Persons Aged <25
Years Before and During the COVID-19 Pandemic" under COVID
Complications).
As the rollout of the newly formulated COVID-19 booster shot begins in
earnest, many Americans are finding roadblocks (see "Shortages, Cost,
and Frustration: Quest for the New COVID Shot" under Policy).
Relatives of COVID ICU patients demonstrate a range of coping styles
and impact on quality of life (see "Quality of Life and Coping With
Stress in Relatives of Patients in Intensive Care Units During
COVID-19" under COVID Complications).
The biotech Moderna said Wednesday that its first combination vaccine,
which protects against influenza and Covid-19, had succeeded in an
early-stage trial and could be ready to launch as soon as 2025 (see
"Moderna’s Combo Vaccine Moves Towards Late-Stage Trial" under
Vaccines, Treatment & Testing).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @PsychResearchBot
So, one of my favourite #conferences is happening in two weeks. The program looks fantastic. There is also an #accessibility FAQ page. Nice!
Except... does the page mention #covid? No. Maybe the "hybrid experience" page mentions #covid19? No. Nothing on any 'attend' page mentions anything pandemic. You can assure yourself that the venue is non-smoking, but the word "mask" is absent. 🤷♂️ This is what collective denial looks like.
Do better. #CovidIsNotOver#COVIDisAirborne@academicchatter
As an autistic child, I would get in trouble for not doing tasks other kids instinctively did. I’d respond with “I didn’t know I needed to do XYZ - I hadn’t been told to”. This would cause uproar, as seeing others do things should’ve “influenced” me. It did not and yet all these years later.. It still doesn’t.
‘It will happen’: Need to prepare for new pandemic and what we’ll likely be hit with next.
A Melbourne-made COVID vaccine that shows great promise in protecting against Omicron’s many deadly mutations could be mass produced and rolled out across the globe.
"Law experts from Charles Darwin University say the Covid-19 pandemic inquiry must focus on all levels of government to deal effectively with the lessons learned, not just the commonwealth response."
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: Hospitalizations from COVID-19 rose for an eighth straight
week to 18,871 people/week see "COVID Hospitalizations Rise for Eighth
Week in a Row" under Virology & Epidemiology).
Moderna says its upcoming COVID-19 vaccine should work against the
BA.2.86 variant that has caused worry about a possible surge in cases
(see "New Moderna Vaccine to Work Against Recent COVID Variant" under
Vaccomes, Treatment & Testing).
COVID vaccines will have a new formulation this year, according to a
decision announced today by the US Food and Drug Administration that
will focus efforts on circulating variants. The move pushes last
year's bivalent vaccines out of circulation because they will no
longer be authorized for use in the United States (see "New COVID
Vaccines Force Bivalents Out" under Policy).
The CDC is not specifically saying whether long COVID patients should
get the new COVID boosters, flu shots, or RSV vaccines, and the Food
and Drug Administration (FDA) referred similar questions to the CDC
(see "Should Long COVID Patients Get the Flu, RSV, and New Booster
Shots?" under Policy).
Research continues to show that early intervention with antibiotics
reduces the risk of fatality from COID-19 (see "Early Empiric
Antibiotic Use in Patients Hospitalized With COVID-19" under Vaccines,
Treatment & Testing).
In ICU-patients ≥70 years old, COVID-19 is associated with greater
mortality rates than bacterial or viral pneumonia (see "Increased
Mortality in ICU Patients ≥70 Years Old With COVID-19 Compared to
Patients With Other Pneumonias" under COVID Complications).
After the US Food and Drug Administration authorized new monovalent
COVID vaccines, the CDC recommended the new booster vaccinations for
everyone (see "Universal Monovalent COVID Vaccines Backed by CDC"
under Policy).
About 103 million Americans had COVID-19, and about a third of those
led to long COVID. New data indicate that some cases of long COVID-19
might be going unidentified because the patient's initial infection
wasn't detected (see "Some People With Long COVID Tested Negative for
COVID-19" under COVID Complications).
Although SARS-CoV-2 infection among young children typically results
in mild infection, it can result in serious illness, including
multisystem inflammatory syndrome in children, long-term sequalae, and
death. mRNA COVID-19 vaccination provides protection against
symptomatic SARS-CoV-2 infection for at least 4 months after
vaccination among children aged 3–5 years (see "Safety Monitoring of
mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5
Years" under Vaccines, Treatment & Testing).
A new meta-analysis has shown that SGLT2 inhibitors do not lead to
lower 28-day all-cause mortality compared with usual care or placebo
in patients hospitalized with COVID-19 (see "SGLT2-inhibitors: No
Benefit in Hospitalized COVID-19" under Vaccines, Treatment &
Testing).
The COVID-19 booster vaccine typically causes transient, clinically
insignificant elevations in glucose levels in people with type 1
diabetes (see "COVID Booster May Transiently Raise Glucose Levels in
T1D" under Vaccines, Treatment & Testing).
"Cost May Lead Many to Skip COVID Testing: Why That's a Problem" (see
under Media News).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog #stillnotover
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
“COVID is a reminder that infectious disease remains a fundamental threat. The pandemic has killed tens of millions of people, wreaked long-term harm on the health of many more, and triggered global economic disruption.”
I used to casually play chess with people as a way to interact socially. Not all the time, just like someone might pull out some playing cards and say "hey let's play Go Fish" or whatever. It was usually a pretty even match with neither side being Super Into Chess. Sometimes I'd get to the point in the game where they had taken everything but the king. They would tell me to give up.
Disclaimer: The data in this column come from either mainstream news
media sources or scientific research published in peer-reviewed
journals (each category can be determined by following the links in
the reference section). This column's author acknowledges the cultural
bias of the world scientific community in its belief that the
scientific method is the most viable available alternative for
assessing COVID-19 and its effects in an objective manner through a
structured process of observable and repeatable hypothesis testing.
Summary: The updated vaccine that better protects against currently
circulating strains of the virus that causes COVID-19 may be available
as soon as next week (see "New COVID Shots Could Be Available Next
Week" under Vaccines, Treatment & Testing).
The increase in cases of COVID-19 in the northern hemisphere is
worrying healthcare authorities around the world, who are aware that
these countries usually experience a peak in respiratory infections
during the winter months (see "WHO 'Concerned' About COVID Increase in
Northern Hemisphere" under Virology & Epidemiology).
COVID-19 hospitalizations have been on the rise for weeks as summer
nears its end. COVID-19 hospitalizations rose by 19% last week and
COVID deaths by 21%, according to figures from the CDC. More than half
the states, 26, had a "substantial increase" in hospital admissions
(see "COVID-19 Hospitalizations and Deaths on the Rise" and "5
Questions for COVID Experts: How Concerned Should We Be?" under
Virology & Epidemiology).
COVID metrics have risen steadily since June after reaching the lowest
point since the pandemic started. However, just 7% of U.S. adults are
"very worried" about getting COVID-19 (see "COVID Metrics Tick Up, but
Americans Aren't Worried: Poll" under Media News).
The CDC and the World Health Organization have dubbed the BA 2.86
variant of COVID-19 as a variant to watch (see "Q&A: What to Know
About the New BA 2.86 COVID Variant" under Virology & Epidemiology).
However, BA.2.86 does not have a heightened ability to evade the
protection of COVID vaccines or immunity from prior infection (see
"Highly Mutated COVID Strain Can't Evade Immunity as Feared" under
Virology & Epidemiology).
Close and prolonged contact with someone with COVID-19 can more than
quadruple the risk of getting the virus (see "This Is When You're Most
at Risk for 'Leaky' COVID Immunity" under Virology & Epidemiology).
It's estimated that 1 out of 8 people with COVID develop long COVID.
Of those persons, 44% also experience headaches. Research has found
that many of those headaches are migraines — and many patients who are
afflicted say they had never had a migraine before (see "Long COVID
and New Migraines: What's the Link?" under COVID Complications).
Severe COVID infections may lead to lasting damage to the immune
system (see "Severe COVID May Cause Long-Term Cellular Changes: Study"
under COVID Complications).
COVID-19 may negatively affect the wound healing process while
increasing the mortality rate amongst patients with multiple or severe
comorbidities undergoing limb salvage procedure (see "Retrospective
Review of Complications and Outcomes in COVID-19–Positive Patients
With Comorbidities Undergoing Limb Salvage Procedures in a Tertiary
Care Wound Center" under COVID Complications).
Among patients with ARF due to COVID-19 pneumonia who fail HFNC, delay
of intubation beyond 24 h is associated with increased mortality (see
"Delayed Intubation Associated With In-hospital Mortality in Patients
With COVID-19" under Vaccines, treatment & Testing).
Crippling symptoms, lost careers, and eroded incomes: This is the
harsh reality for doctors suffering with long COVID, according to the
first major survey of physicians with the condition (see "One in Five
Doctors With Long COVID Can No Longer Work: Survey" under COVID
Complications).
EU regulators have recommended authorizing an updated COVID-19 vaccine
from Pfizer and its German partner BioNTech which targets the dominant
XBB.1.5 variant of Omicron, putting it on track to become the third
adapted shot by the two companies to be approved in the bloc (see "EU
Regulators Back Pfizer's Updated Vaccine for Dominant Omicron
Subvariant" under Policy).
The May 11, 2023 termination of the PHE has made it increasingly
difficult to accurately track COVID-19 new cases or fatalities.
However, new variants of concern continue to emerge, with consequent
infections and deaths.
Since the termination of the PHE, data on vaccination rates are no
longer being tracked. The last known US COVID-19 vaccination rates
(May 10, 2023) are as follows: full
vaccination (two initial doses) 69.3%; at least one updated booster
dose: 17% (see "Track Covid-19 in the U.S." under
Vaccines, Treatment & Testing). "Our World in Data" stopped trying to
track US booster rates on August 30, 2022 and shows a flat line since
then.
Charles M. Lepkowsky, Ph.D.
Solvang, CA
clepkowsky(at)gmail.com
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
Okay all -- It's early days for figuring out how to help people with
Long COVID.
That said, a bit of promising research is starting to surface.
I'm taking the unusual step of emailing EVERYONE because at this point
many of you with anxiety and depression symptoms may have some Long
COVID (brain fog, sleep issues, the depression or anxiety itself!).
A good write-up about what Long COVID is can be found here. Yes, you
can had a trivial case of COVID-19 and still get Long COVID symptoms for
days, weeks, months, or years. Some cases of it are somewhat "mild": https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
*The bottom-line of the video is right at the end. For long COVID:
-- Get outside one hour per day.
-- May cover up if sensitive to sun (near UV rays will get through
clothing anyway)
-- Best if in nature (surrounded by green)
-- Do not look directly at sun (duh)
-- May wear a hat (near UV rays will get through clothing anyway)
-- Sitting in a sunny window no longer good enough (most glass now has
to be certified to block the rays we want)
He also promises to talk about how intermittent fasting may help in a
future video.
*
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical
Care, and Sleep Medicine and an Associate Professor at the University of
California, Riverside School of Medicine. He is also an ER doctor.
Before the pandemic, MedCram mainly seemed to be training for doctors to
pass exams. Since the start of COVID, Dr. Seheult has done occasional
more accessible videos for the general public on COVID-related topics.
To actually understand why something this simple may help -- and listen
to some research, please watch:
#psychology #counseling #socialwork #psychotherapy #research
@[email protected] @[email protected] @[email protected]
@[email protected] #Vaccines #COVID #longcovid #science #medicine
#covid19 #coronavirus #sars-cov-2 #covidisnotover #CDC
@[email protected] @[email protected] @[email protected]
#depression #anxiety #sleep #brainfog
.
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can subscribe at @[email protected]
"The band Smash Mouth did not feel any need to avoid the elephant in the room ...that the socially un-distanced gathering could be a breeding ground for a coronavirus “super-spreader event.”
“F— that COVID s—!” singer Steve Harwell could be heard telling the crowd in video footage. “Now we’re all here together tonight.”
As a preventative measure for SeaLions / Strawmanners:
Here is what I implied.
▫️Motherfucker is dead
▫️Motherfucker is dead young
▫️Motherfucker was in Smash Mouth
▫️Motherfucker promoted super spreading events before vaccines
▫️ Presumably being a rock band mbr, MFer drank and partied!
▫️COVID infects ACE2 rich cells, such as cholangiocytes and hepatocytes
▫️ Maybe Motherfucker gets 5-7 more quality-adjusted life years (QALY) if he didnt FAFO.
Found an angle to sleep at that didn't send me into paroxysms of searing coughs, so I got a couple hours of sleep. Now to attempt to recapture the magic. #COVID#COVID19#CovidIsNotOver
Bon je voulais mettre à jour mon tract covid précédent avec un point sur la situation actuelle du covid, mais finalement j’ai fait un thread entier car il y a trop de choses à dire (et que je sais pas résumer, oui bon).
Je sais que c’est long, mais il y a beaucoup de trucs à expliquer et de propagande à déconstruire, et si les gens qui commencent à lire sont un peu de bonne foi, il y a ptètre une chance qu’iels continuent.
Sinon ça peut aussi sûrement servir comme base pour faire quelque chose de plus réduit et accessible (ce que je sais pas faire donc, mais servez-vous).
Je mets l’ensemble de ce thread dans le domaine public (en fait, techniquement, sous licence CC0, mais c'est tout comme), donc vous pouvez en faire des copier-coller tant que vous voulez sans même avoir à me mentionner, ou réécrire des bouts, modifier, etc.
Si vous utilisez ça pour en faire un tract (genre un 4 pages) ou un truc plus court et accessible, n’hésitez pas à poster le résultat en réponse. C’est peut-être aussi possible de travailler collectivement sur une version plus réduite via un pad HedgeDoc ou autre truc, mais j’ai pas la motivation de gérer ça donc je vous laisse faire).
Tous les commentaires sont les bienvenus, notamment s’il y a des erreurs factuelles à corriger.
Si vous ne voyez pas la mise en page correctement (exemples : gras, italique, barré), c’est peut-être parce que votre instance de mastodon ne prend pas en compte le markdown, donc ouvrez-le directement sur eldritch.cafe via le lien de ce pouet : https://eldritch.cafe/@jor/110921862954460640
Per @marcdaalder on #newsroomNZ
“Scrapping the remaining measures protecting the public from Covid-19 is foolhardy and inconsistent with the approach we take to other threats to our collective welfare.“